eJHaem
(Nov 2023)
Favorable outcomes of DDX41‐mutated myelodysplastic syndrome and low blast count acute myeloid leukemia treated with azacitidine ± lenalidomide
- Ing S. Tiong,
- William S. Stevenson,
- Meaghan Wall,
- Yan Zhuang Yap,
- John F. Seymour,
- Melita Kenealy,
- Piers Blombery,
- the Australasian Leukaemia & Lymphoma Group
Affiliations
- Ing S. Tiong
- Peter MacCallum Cancer Centre Melbourne Victoria Australia
- William S. Stevenson
- Royal North Shore Hospital St Leonards New South Wales Australia
- Meaghan Wall
- Monash University Melbourne Victoria Australia
- Yan Zhuang Yap
- Peter MacCallum Cancer Centre Melbourne Victoria Australia
- John F. Seymour
- Peter MacCallum Cancer Centre Melbourne Victoria Australia
- Melita Kenealy
- Monash University Melbourne Victoria Australia
- Piers Blombery
- Peter MacCallum Cancer Centre Melbourne Victoria Australia
- the Australasian Leukaemia & Lymphoma Group
- Peter MacCallum Cancer Centre Melbourne Victoria Australia
- DOI
-
https://doi.org/10.1002/jha2.767
- Journal volume & issue
-
Vol. 4,
no. 4
pp.
1212
– 1215
WeChat QR code
